YANKCOM Partnership

SEC CIK: 0002036975
Latest filing: Jul 21, 2026

SEC filings (opens in a new tab)

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by YANKCOM Partnership, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overview All 13F holders of RXRX Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2025

Holdings of RXRX by YANKCOM Partnership, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−300−100.0%	Sold out	Holders
Q1 2026	300	$921	<0.1%	00.0%	Unchanged	Holders
Q4 2025	300	$1.23K	<0.1%	+300	New	Holders